Post-translational modifications (PTMs) are where so much of...
Read More Phosphorylation, ADMA, and O-GlcNAc Analysis on the Orbitrap Excedion Pro Mass Spectrometer
From Archived FFPE Tissues to Biomarker Insights in a Day
Formalin-fixed, paraffin-embedded (FFPE) tissue is one of th...
Read More From Archived FFPE Tissues to Biomarker Insights in a Day
One Injection, Two Answers: Introducing Squad Metabolomics on Or...
Metabolomics researchers are often forced to choose between ...
Read More One Injection, Two Answers: Introducing Squad Metabolomics on Orbitrap Mass Spectrometers
4.5-Minute Oral Fluid LC MS Method to Detect 31 Drugs of Abuse U...
Summary This workflow confirms and quantifies 31 drugs of ab...
Read More 4.5-Minute Oral Fluid LC MS Method to Detect 31 Drugs of Abuse Using Stellar MS
Breaking Sensitivity Barriers: How MS³ is Transforming Biomarke...
Introduction At the recent Thermo Fisher Scientific sponsore...
Read More Breaking Sensitivity Barriers: How MS³ is Transforming Biomarker Discovery for ALS and Beyond
Purpose-Built Software for Quantitation Workflows – Solving Da...
In our recent blog on selecting software for targeted MS qua...
Read More Purpose-Built Software for Quantitation Workflows – Solving Data, Compliance, and Collaboration Challenges
Cracking the Code of PEGylated Proteins: How Advanced Mass Spect...
In the world of biotherapeutics, bigger often means better ...
Read More Cracking the Code of PEGylated Proteins: How Advanced Mass Spectrometry Reveals What’s Really Attached
Electrospray 101: What to Know About LC-MS Sources – and a...
1. What exactly is a “source” in mass spectrometry? Whet...
Read More Electrospray 101: What to Know About LC-MS Sources – and a First Look at Optispray
Thermo Fisher Scientific at ICRAV 2026
March 22 to 29, 2026 | Visit us at booth #28 Thermo Fisher S...
Read More Thermo Fisher Scientific at ICRAV 2026
Accelerating Biomarker Discovery and Validation: From Discovery ...
At MSACL 2025, a Thermo Fisher Scientific–sponsored worksh...
Read More Accelerating Biomarker Discovery and Validation: From Discovery to Clinical Utility